“…Several reviews and commentaries covering the findings and applications of visual electrophysiology in central nervous system (CNS) disorders have been published in the last decade advocating the retina as a “window to the brain” ( London et al, 2013 ; Lavoie et al, 2014b , c ; Gagné et al, 2015 ; Nguyen et al, 2017 ; Youssef et al, 2019 ; Silverstein and Thompson, 2020 ; Diamond et al, 2022 ; Silverstein et al, 2022 ; Schwitzer et al, 2022b , c ; Alves et al, 2023 ; Mahroo, 2023 ; Tursini et al, 2023 ) and on using the electroretinogram (ERG) to differentiate schizophrenia and bipolar disorder ( Lavoie et al, 2014b ; Hébert et al, 2015 , 2020 ; Hosak et al, 2018 ; Almonte et al, 2020 ; Peredo et al, 2020 , 2022 ; Silverstein et al, 2020 , 2022 ; Maziade et al, 2022 ; Moreau et al, 2022 ; Tursini et al, 2022 ). To understand the landscape of potential retinal biomarkers in CNS disorders, here we review studies encompassing schizophrenia, bipolar disorder, autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), seasonal affective disorder, major depressive disorder, Parkinson’s disease (PD) and Alzheimer’s disease (AD).…”